CHILDREN'S NYQUIL COLD & COUGH OTC
Generic Name and Formulations:
Chlorpheniramine maleate 2mg, dextromethorphan HBr 15mg; per 15mL; liq; cherry flavor; alcohol-free; contains sodium 71mg/15mL.
Procter & Gamble Pharmaceuticals
Indications for CHILDREN'S NYQUIL COLD & COUGH:
Cough, sneezing, rhinorrhea.
Adults and Children:
<6yrs: not recommended. 6–11yrs: 15mL. ≥12yrs: 30mL. All: repeat every 6 hours; max 4 doses/24 hours.
During or within 14 days of MAOIs.
GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Sodium-restricted diet. Pregnancy. Nursing mothers.
See Contraindications. Hypertensive crisis with MAOIs. Avoid alcohol. Increased CNS effects with other CNS depressants.
Antihistamine + antitussive.
Drowsiness, anticholinergic effects, excitability in children.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies